Showing results (1681-1690 of 2,295) with videos related to
Sort By:
Pageof 230
Mbio|October 24, 2013
Small genomes and sparse metabolisms of sediment-associated bacteria from four candidate phylaRose S Kantor, Kelly C Wrighton, Kim M Handley, et al.Journal of the American College of Surgeons|April 15, 2017
Using the NSQIP Pancreatic Demonstration Project to Derive a Modified Fistula Risk Score for Preoperative Risk Stratification in Patients Undergoing PancreaticoduodenectomyOlga Kantor, Mark S Talamonti, Henry A Pitt, et al.Plos One|April 12, 2012
Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasisYumiko Wada, Irma Cardinale, Artemis Khatcherian, et al.Plos One|February 27, 2015
Randomized trial of glucosamine and chondroitin supplementation on inflammation and oxidative stress biomarkers and plasma proteomics profiles in healthy humansSandi L Navarro, Emily White, Elizabeth D Kantor, et al.Physiological Research|January 9, 2026
Post-Operative Atrial Fibrillation: Novel Predictive Value of CT-Derived Adipose Tissue Density in Minimally Invasive Mitral SurgeryM Pekar, D Vician, O Jiravsky, et al.Journal of Medical Economics|August 6, 2010
Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalinNoam Y Kirson, Jasmina I Ivanova, Howard G Birnbaum, et al.Journal of Medical Economics|August 6, 2010
Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%Noam Y Kirson, Jasmina I Ivanova, Howard G Birnbaum, et al.Analytical Chemistry|April 30, 2015
Ten-atom silver cluster signaling and tempering DNA hybridizationJeffrey T Petty, Orlin O Sergev, Andrew G Kantor, et al.Frontiers in Neuroscience|May 17, 2021
Cell-Type Specific Changes in DNA Methylation of SNCA Intron 1 in Synucleinopathy BrainsJeffrey Gu, Julio Barrera, Young Yun, et al.Antimicrobial Agents and Chemotherapy|March 19, 2002
Evolution of primary protease inhibitor resistance mutations during protease inhibitor salvage therapyRami Kantor, W Jeffrey Fessel, Andrew R Zolopa, et al.Pageof 230